• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Parkinson's Disease and Related Disorders Part II

Parkinson's Disease and Related Disorders Part II

Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab)

9780444528933
907.20 zł
816.48 zł Save 90.72 zł Tax included
Lowest price within 30 days before promotion: 816.48 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The two volumes on Parkinsons disease in the Handbook of Clinical Neurology (Series Editors:: Michael J. Aminoff, Department of Neurology, University of California, San Francisco, USA; François Boller, Bethesda, USA; Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands) cover a group of disorders that constitute the commonest of neurodegenerative diseases and one that is assuming ever greater importance with the ageing of the population in developed countries. The coverage reflects the dramatic advances in understanding of the biochemical background of parkinsonism and the resulting developments in the pharmacological management of the disease. These volumes give a comprehensive account of the subject for both clinical neurologists and those researching in the neurosciences.

Part I covers the scientific background, general aspects of Parkinsons disease, clinical aspects and etiology. Part II covers the medical and surgical treatment of Parkinsons disease, complications of therapy and the other parkinsonian syndromes.
Product Details
35011
9780444528933
9780444528933

Data sheet

Publication date
2007
Issue number
1
Cover
hard cover
Pages count
608
Dimensions (mm)
246 x 189
Weight (g)
1873
  • Section 5: Treatment of Parkinsons disease
    Physical therapy in Parkinsons disease. Neuroprotection in Parkinsons disease: clinical trials. Levodopa. Dopamine agonists. Monoamine oxidase A and B inhibitors in Parkinsons disease. Anticholinergic medications. Antiglutamatergic drugs in the treatment of Parkinsons disease. Investigational drugs. The importance of patients groups and collaboration
    Section 6: Complications of therapy
    Motor and non-motor fluctuations. Levodopa-induced dyskinesias in Parkinsons disease. Treatment induced mental changes in Parkinsons disease.
    Section 7 Surgical treatment
    Ablative surgery for the treatment of Parkinsons disease. Deep brain stimulation. Transplantation. Gene therapy approaches for the treatment of Parkinsons disease.
    Section 8: Other parkinsonian disease syndromes
    Multiple system atrophy. Progressive supranuclear palsy. Corticobasal degeneration. Infectious basis to the pathogenesis of Parkinsons disease. Toxic causes of Parkinsons disease. Drug induced parkinsonism. Vascular parkinsonism. Old age and Parkinsons disease. Other degenerative processes. Hydrocephalus and structural lesions. Calcification of the basal ganglia. Trauma and Parkinsons disease. Psychogenic parkinsonism. Parkinsonism and dystonia. Dementia with Lewy bodies. Myoclonus and parkinsonism.
Comments (0)